Expression profiling of mitochondrial voltage-dependent anion channel-1 associated genes predicts recurrence-free survival in human carcinomas

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Ko, Jae Hong ^a   Gu, Wanjun ^b   Lim, Inja ^a   Zhou, Tong ^c   Bang, Hyoweon ^a  

^a Chung Ang University   (South Korea)

^b SOUTHEAST UNIVERSITY   (China)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VOLTAGE DEPENDENT ANION CHANNEL 1; TRANSCRIPTOME;

ARTICLE; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOMA; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PANCREAS CARCINOMA; RECURRENCE FREE SURVIVAL; SEX DIFFERENCE; THYROID CARCINOMA; UPREGULATION; VDAC1 GENE; BIOLOGY; EPISTASIS; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; MITOCHONDRION; MORTALITY; NUCLEIC ACID DATABASE; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR RECURRENCE;

CARCINOMA; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; EPISTASIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MITOCHONDRIA; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TRANSCRIPTOME; VOLTAGE-DEPENDENT ANION CHANNEL 1;

EID: 84908110262     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110094     Document Type: Article

References (62)

1. Hoogenboom BW, Suda K, Engel A, Fotiadis D (2007) The supramolecular assemblies of voltage-dependent anion channels in the native membrane. J Mol Biol 370: 246-255.
2. Benz R (1994) Permeation of hydrophilic solutes through mitochondrial outer membranes: review on mitochondrial porins. Biochim Biophys Acta 1197: 167-196.
3. Dihanich M (1990) The biogenesis and function of eukaryotic porins. Experientia 46: 146-153.
4. Blachly-Dyson E, Forte M (2001) VDAC channels. IUBMB Life 52: 113-118.
5. De Pinto V, Messina A, Lane DJ, Lawen A (2010) Voltage-dependent anionselective channel (VDAC) in the plasma membrane. FEBS Lett 584: 1793-1799.
6. Okada SF, O'Neal WK, Huang P, Nicholas RA, Ostrowski LE, et al. (2004) Voltage-dependent anion channel-1 (VDAC-1) contributes to ATP release and cell volume regulation in murine cells. J Gen Physiol 124: 513-526.
7. Lemasters JJ, Holmuhamedov E (2006) Voltage-dependent anion channel (VDAC) as mitochondrial governator-thinking outside the box. Biochim Biophys Acta 1762: 181-190.
8. Shoshan-Barmatz V, Keinan N, Abu-Hamad S, Tyomkin D, Aram L (2010) Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo. Biochim Biophys Acta 1797: 1281-1291.
9. Tan W (2012) VDAC blockage by phosphorothioate oligonucleotides and its implication in apoptosis. Biochim Biophys Acta 1818: 1555-1561.
10. Tsujimoto Y, Shimizu S (2002) The voltage-dependent anion channel: an essential player in apoptosis. Biochimie 84: 187-193.
11. Leanza L, Zoratti M, Gulbins E, Szabo I (2014) Mitochondrial ion channels as oncological targets. Oncogene.
12. Krasnov GS, Dmitriev AA, Lakunina VA, Kirpiy AA, Kudryavtseva AV (2013) Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy. Expert Opin Ther Targets 17: 1221-1233.
13. Simamura E, Shimada H, Hatta T, Hirai K (2008) Mitochondrial voltagedependent anion channels (VDACs) as novel pharmacological targets for anticancer agents. J Bioenerg Biomembr 40: 213-217.
14. Mathupala SP, Pedersen PL (2010) Voltage dependent anion channel-1 (VDAC- 1) as an anti-cancer target. Cancer Biol Ther 9: 1053-1056.
15. Koren I, Raviv Z, Shoshan-Barmatz V (2010) Downregulation of voltagedependent anion channel-1 expression by RNA interference prevents cancer cell growth in vivo. Cancer Biol Ther 9: 1046-1052.
16. Perevoshchikova IV, Zorov SD, Kotova EA, Zorov DB, Antonenko YN (2010) Hexokinase inhibits flux of fluorescently labeled ATP through mitochondrial outer membrane porin. FEBS Lett 584: 2397-2402.
17. Ko JH, Gu W, Lim I, Bang H, Ko EA, et al. (2014) Ion channel gene expression in lung adenocarcinoma: potential role in prognosis and diagnosis. PLoS One 9: e86569.
18. Ko JH, Ko EA, Gu W, Lim I, Bang H, et al. (2013) Expression profiling of ion channel genes predicts clinical outcome in breast cancer. Mol Cancer 12: 106.
19. Pitroda SP, Zhou T, Sweis RF, Filippo M, Labay E, et al. (2012) Tumor endothelial inflammation predicts clinical outcome in diverse human cancers. PLoS One 7: e46104.
20. Grills C, Jithesh PV, Blayney J, Zhang SD, Fennell DA (2011) Gene expression meta-analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer. PLoS One 6: e14635.
21. Pau Ni IB, Zakaria Z, Muhammad R, Abdullah N, Ibrahim N, et al. (2010) Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context. Pathol Res Pract 206: 223-228.
22. Uddin S, Ahmed M, Hussain A, Abubaker J, Al-Sanea N, et al. (2011) Genomewide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy. Am J Pathol 178: 537-547.
23. Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, et al. (2010) A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res 70: 10202-10212.
24. Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA, Pedraza V, Boyero L, et al. (2011) Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. Int J Cancer 129: 355-364.
25. Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I (2008) Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 55: 2016-2027.
26. Sabatier R, Finetti P, Cervera N, Lambaudie E, Esterni B, et al. (2011) A gene expression signature identifies two prognostic subgroups of basal breast cancer. Breast Cancer Res Treat 126: 407-420.
27. Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, et al. (2011) A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305: 1873-1881.
28. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, et al. (2010) Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138: 958-968.
29. Marisa L, de Reynies A, Duval A, Selves J, Gaub MP, et al. (2013) Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med 10: e1001453.
30. Lee ES, Son DS, Kim SH, Lee J, Jo J, et al. (2008) Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin Cancer Res 14: 7397-7404.
31. Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, et al. (2012) Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALKnegative lung adenocarcinomas. Cancer Res 72: 100-111.
32. Wu ZJ, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F (2004) A model-based background adjustment for oligonucleotide expression arrays. Journal of the American Statistical Association 99: 909-917.
33. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D (1998) GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics 14: 656-664.
34. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D (1997) GeneCards: integrating information about genes, proteins and diseases. Trends Genet 13: 163.
35. Chatr-Aryamontri A, Breitkreutz BJ, Heinicke S, Boucher L, Winter A, et al. (2013) The BioGRID interaction database: 2013 update. Nucleic Acids Res 41: D816-823.
36. Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163.
37. UniProt C (2014) Activities at the Universal Protein Resource (UniProt). Nucleic Acids Res 42: D191-198.
38. Magrane M, Consortium U (2011) UniProt Knowledgebase: a hub of integrated protein data. Database-the Journal of Biological Databases and Curation.
39. Licata L, Briganti L, Peluso D, Perfetto L, Iannuccelli M, et al. (2012) MINT, the molecular interaction database: 2012 update. Nucleic Acids Res 40: D857- 861.
40. Chatr-aryamontri A, Ceol A, Palazzi LM, Nardelli G, Schneider MV, et al. (2007) MINT: the Molecular INTeraction database. Nucleic Acids Res 35: D572-574.
41. Brown KR, Jurisica I (2007) Unequal evolutionary conservation of human protein interactions in interologous networks. Genome Biol 8: R95.
42. Brown KR, Jurisica I (2005) Online predicted human interaction database. Bioinformatics 21: 2076-2082.
43. von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, et al. (2003) STRING: a database of predicted functional associations between proteins. Nucleic Acids Res 31: 258-261.
44. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, et al. (2013) STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41: D808-815.
45. Huynh-Thu VA, Irrthum A, Wehenkel L, Geurts P (2010) Inferring regulatory networks from expression data using tree-based methods. PLoS One 5.
46. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
47. Mi H, Muruganujan A, Thomas PD (2013) PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res 41: D377-386.
48. Venet D, Dumont JE, Detours V (2011) Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol 7: e1002240.
49. O'Rourke B (2007) Mitochondrial ion channels. Annu Rev Physiol 69: 19-49.
50. Leanza L, Biasutto L, Manago A, Gulbins E, Zoratti M, et al. (2013) Intracellular ion channels and cancer. Front Physiol 4: 227.
51. Sillars-Hardebol AH, Carvalho B, Belien JA, de Wit M, Delis-van Diemen PM, et al. (2012) BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain. J Pathol 226: 442-450.
52. Zhu H, Zhu Y, Hu J, Hu W, Liao Y, et al. (2007) Adenovirus-mediated small hairpin RNA targeting Bcl-XL as therapy for colon cancer. Int J Cancer 121: 1366-1372.
53. Vilenchik M, Raffo AJ, Benimetskaya L, Shames D, Stein CA (2002) Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents. Cancer Res 62: 2175-2183.
54. Castilla C, Congregado B, Chinchon D, Torrubia FJ, Japon MA, et al. (2006) Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak. Endocrinology 147: 4960-4967.
55. Mohammad RM, Wang S, Banerjee S, Wu X, Chen J, et al. (2005) Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (-)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line. Pancreas 31: 317-324.
56. Ehrlichova M, Koc M, Truksa J, Naldova Z, Vaclavikova R, et al. (2005) Cell death induced by taxanes in breast cancer cells: cytochrome C is released in resistant but not in sensitive cells. Anticancer Res 25: 4215-4224.
57. Schmitt E, Parcellier A, Ghiringhelli F, Casares N, Gurbuxani S, et al. (2004) Increased immunogenicity of colon cancer cells by selective depletion of cytochrome C. Cancer Res 64: 2705-2711.
58. Koscielny S (2010) Why most gene expression signatures of tumors have not been useful in the clinic. Sci Transl Med 2: 14ps12.
59. Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, et al. (2005) Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A 102: 3738-3743.
60. Lowe SW, Lin AW (2000) Apoptosis in cancer. Carcinogenesis 21: 485-495.
61. Kasibhatla S, Tseng B (2003) Why target apoptosis in cancer treatment? Mol Cancer Ther 2: 573-580.
62. Fernald K, Kurokawa M (2013) Evading apoptosis in cancer. Trends Cell Biol 23: 620-633.